Cargando…
Immunosuppressants and antiviral: COVID-19 and lack of efficacy: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990628/ http://dx.doi.org/10.1007/s40278-022-12949-y |
Ejemplares similares
-
Immunosuppressants/azithromycin: Prolonged COVID-19 infection, off label use and lack of efficacy: case report
Publicado: (2021) -
Antineoplastics/immunosuppressants: Lack of efficacy, graft versus host disease and COVID-19 pneumonia: case report
Publicado: (2021) -
Immunosuppressants/Antifungals: COVID-19 associated mucormycosis, COVID-19 associated pulmonary aspergillosis and lack of efficacy: case report
Publicado: (2022) -
Corticosteroids/immunosuppressants/steroids: COVID-19 and lack of efficacy following off label use: 7 case reports
Publicado: (2022) -
Antivirals/immunosuppressants: COVID-19 infection and off label use: case report
Publicado: (2020)